“By 2030, almost half of the U.S. population will suffer from cardiovascular disease,” said Bertrand Moal, PhD, MD, and CEO of DESKi, in an interview with MD+DI. Worse, he explained, there will not be ...

The milestone signals a new era of access for cardiac care, enabling any healthcare professional to perform diagnostic-grade echos anytime, anywhere. The FDA also approved DESKi’s Predetermined Change ...

BORDEAUX, France--(BUSINESS WIRE)--DESKi, a healthtech company developing AI-powered diagnostic tools in collaboration with clinicians and researchers, today announced the close of a $6 million seed ...

BORDEAUX, France--(BUSINESS WIRE)--HeartFocus, the revolutionary, AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, today announced its U.S. commercial launch.

Training product provides healthcare practitioners, medical schools, and health systems with a simple, effective, and accessible program for mastering cardiac ultrasounds. HeartFocus unveils NEW ...

HeartFocus enters Butterfly Garden, leveraging Butterfly Network's software development kit (SDK) to integrate new AI-powered heart scan software compatible with Butterfly's leading imaging platform ...

DESKi closes $6M seed round thanks to Racine², an impact-focused fund managed by Serena and Makesense, with participation from BNP Paribas Développement, Épopée Gestion, Good Only Ventures, Better ...

The milestone signals a new era of access for cardiac care, enabling any healthcare professional to perform diagnostic-grade echos anytime, anywhere. BORDEAUX, France--(BUSINESS WIRE)--DESKi today ...

FDA-cleared AI-guided cardiac imaging software now available for all U.S healthcare professionals HeartFocus, the revolutionary, AI-enabled cardiac imaging software developed by data-driven medtech ...

The milestone signals a new era of access for cardiac care, enabling any healthcare professional to perform diagnostic-grade echos anytime, anywhere. DESKi today announced FDA clearance for HeartFocus ...